{"<h3>Importance</h3>": [0], "Chronic": [1], "kidney": [2, 36, 47], "disease": [3], "(CKD)": [4], "is": [5, 83], "the": [6, 76, 247], "16th": [7], "leading": [8], "cause": [9], "of": [10, 12, 75, 95, 102, 132, 145, 157, 182, 201, 237, 249], "years": [11], "life": [13], "lost": [14], "worldwide.": [15, 78, 251], "Appropriate": [16], "screening,": [17], "diagnosis,": [18], "and": [19, 38, 89, 112, 120, 127, 140, 164, 172, 195, 230, 234], "management": [20, 131], "by": [21, 239], "primary": [22, 240], "care": [23, 241], "clinicians": [24, 242], "are": [25, 243], "necessary": [26], "to": [27, 73, 87, 166, 226], "prevent": [28], "adverse": [29], "CKD-associated": [30], "outcomes,": [31], "including": [32], "cardiovascular": [33, 135], "disease,": [34, 37], "end-stage": [35], "death.": [39], "<h3>Observations</h3>": [40], "Defined": [41], "as": [42, 108, 185], "a": [43, 227], "persistent": [44], "abnormality": [45], "in": [46, 219, 245], "structure": [48], "or": [49, 151, 216], "function": [50], "(eg,": [51, 138, 147, 160, 169, 204], "glomerular": [52], "filtration": [53], "rate": [54], "[GFR]": [55], "&lt;60": [56], "mL/min/1.73": [57, 208], "m<sup>2</sup>or": [58], "albuminuria": [59, 121, 146, 210], "\u226530": [60], "mg": [61, 212], "per": [62, 213], "24": [63, 214], "hours)": [64], "for": [65, 180], "more": [66], "than": [67, 93], "3": [68], "months,": [69], "CKD": [70, 82, 99, 133, 202, 238, 250], "affects": [71], "8%": [72], "16%": [74], "population": [77], "In": [79], "developed": [80], "countries,": [81], "most": [84], "commonly": [85], "attributed": [86], "diabetes": [88], "hypertension.": [90], "However,": [91], "less": [92], "5%": [94], "patients": [96], "with": [97], "early": [98], "report": [100], "awareness": [101], "their": [103], "disease.": [104], "Among": [105], "individuals": [106], "diagnosed": [107], "having": [109], "CKD,": [110, 183], "staging": [111], "new": [113], "risk": [114, 136, 200], "assessment": [115], "tools": [116], "that": [117], "incorporate": [118], "GFR": [119, 206], "can": [122], "help": [123], "guide": [124], "treatment,": [125], "monitoring,": [126], "referral": [128, 236], "strategies.": [129], "Optimal": [130], "includes": [134], "reduction": [137], "statins": [139], "blood": [141], "pressure": [142], "management),": [143], "treatment": [144], "angiotensin-converting": [148], "enzyme": [149], "inhibitors": [150], "angiotensin": [152], "II": [153], "receptor": [154], "blockers),": [155], "avoidance": [156], "potential": [158], "nephrotoxins": [159], "nonsteroidal": [161], "anti-inflammatory": [162], "drugs),": [163], "adjustments": [165], "drug": [167], "dosing": [168], "many": [170], "antibiotics": [171], "oral": [173], "hypoglycemic": [174], "agents).": [175], "Patients": [176], "also": [177], "require": [178], "monitoring": [179], "complications": [181], "such": [184], "hyperkalemia,": [186], "metabolic": [187], "acidosis,": [188], "hyperphosphatemia,": [189], "vitamin": [190], "D": [191], "deficiency,": [192], "secondary": [193], "hyperparathyroidism,": [194], "anemia.": [196], "Those": [197], "at": [198], "high": [199], "progression": [203], "estimated": [205, 220], "&lt;30": [207], "m<sup>2</sup>,": [209], "\u2265300": [211], "hours,": [215], "rapid": [217], "decline": [218], "GFR)": [221], "should": [222], "be": [223], "promptly": [224], "referred": [225], "nephrologist.": [228], "<h3>Conclusions": [229], "Relevance</h3>": [231], "Diagnosis,": [232], "staging,": [233], "appropriate": [235], "important": [244], "reducing": [246], "burden": [248]}